The global molecular imaging market was valued at USD 2.19 billion in 2024 and is expected to grow to USD 2.32 billion in 2025, reaching USD 3.46 billion by 2032. This reflects a compound annual growth rate (CAGR) of 5.9% during the forecast period. In 2024, North America held the largest share of the molecular imaging market, accounting for 63.83% of the total market.
The molecular imaging market is experiencing steady growth as demand increases for accurate, non-invasive diagnostic tools across various medical fields, including oncology, cardiology, and neurology. This advanced imaging approach enables real-time visualization of biological processes at the molecular and cellular levels, enhancing early disease detection and personalized treatment planning. Technological innovations, along with rising investment in healthcare infrastructure and research, are supporting broader adoption. As awareness of precision medicine continues to grow, the molecular imaging market is expected to expand further in both developed and emerging regions.
Continue reading for more details:
https://www.fortunebusinessinsights.com/molecular-imaging-market-112879
Market Segmentation
By modality, the molecular imaging market is segmented into PET, SPECT, and hybrid imaging systems such as PET/CT and PET/MRI.
By application, it covers oncology, cardiology, neurology, infectious diseases, and inflammatory disorders, with oncology dominating the molecular imaging market.
By end-user, the molecular imaging market includes hospitals, diagnostic imaging centers, research institutes, and academic centers.
By tracer type, the market includes radiotracers, biomarkers, and targeted molecular probes used in various imaging procedures.
By region, the molecular imaging market is categorized into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
List Of Key Molecular Imaging Companies Profiled:
GE Healthcare (U.S.)
Siemens Healthineers AG (Germany)
Koninklijke Philips N.V. (Netherlands)
Shimadzu Corporation (Japan)
CANON MEDICAL SYSTEMS CORPORATION (Japan)
Bruker (U.S.)
Lantheus Holdings, Inc. (U.S.)
Segami Corporation (U.S.)
Market Growth
The molecular imaging market is witnessing steady growth driven by increasing demand for early disease detection, especially in oncology and neurology.
Rising adoption of advanced imaging technologies for functional and cellular-level diagnostics is significantly boosting the molecular imaging market.
The integration of molecular imaging with AI, radiomics, and hybrid imaging modalities is enhancing diagnostic accuracy and supporting market expansion.
Increased R&D investment in personalized medicine and targeted therapies is fueling the molecular imaging market.
The shift toward non-invasive diagnostic techniques is driving widespread application of solutions within the molecular imaging market.
Restraining Factors
North America leads the molecular imaging market due to advanced healthcare infrastructure, strong reimbursement policies, and high adoption of precision diagnostics.
Europe holds a substantial share in the molecular imaging market, supported by government research funding and growing focus on early cancer diagnosis.
Asia-Pacific is emerging as a fast-growing region in the molecular imaging market, driven by rising healthcare investment, growing disease burden, and technological advancements.
Latin America is showing gradual growth in the molecular imaging market, aided by expanding diagnostic services and increasing awareness of imaging technologies.
Middle East & Africa represent a developing segment of the molecular imaging market, with potential growth linked to public-private partnerships and health sector modernization.
Regional Analysis
North America leads the molecular imaging market, supported by advanced healthcare infrastructure and high R&D investment.
Europe holds a strong position in the molecular imaging market, driven by government-funded research initiatives and disease screening programs.
Asia Pacific is emerging as a fast-growing region in the molecular imaging market, fueled by expanding diagnostic capabilities and growing healthcare expenditure.
The Middle East and Africa show gradual growth in the molecular imaging market due to improving diagnostic imaging access.
Latin America is seeing rising adoption in the molecular imaging market, supported by increased awareness and development of imaging facilities.